Press releases
Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s
Novasep’s robust quality assurance system, fully compliant with the highest world standards, showcased during successful FDA inspection of the Chasse-sur-Rhône (France) facility.
Novasep launches BioSC® Pilot, breakthrough chromatography and DSP skid for biologics purification
BioSC Pilot® is a new tool for continuous and intensified downstream processes in the biopharmaceutical industry.
Novasep invests €10M in “SeneFill”, its new facility for commercial aseptic Fill & Finish operations
This facility, located in Seneffe (Belgium), will strengthen Novasep’s drug product services for mAbs, viral vectors and other low volume biopharmaceuticals
Novasep announces 2017 financial results
Sales are up 4% at 282 M€
EBITDA is up 4.3% at 29 M€
Novasep supplies Complete Process Line to MEFSCO corn milling facility
The starch sweeteners plant will serve the growing Middle Eastern food and beverage market.
Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API
The manufacturing will take place at Novasep’s Chasse sur Rhône site.
Novasep invests €17 M in “mAbulous”, its dedicated cGMP monoclonal antibody (mAb) production facility
The facility will address increasing demand for small-volume mAb CDMO services
Novasep supplies MENA sugar industry leader, Al Nouran
• Egyptian producer Al Nouran’s future sugar production facility integrates Novasep-engineered purification units
• The new plant to address local supply shortage
Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity
Novasep announces €4M investment to install a new cryogenics production line and a new pilot stream at its Chasse-sur-Rhône (FR) facility
Novasep becomes an Authorized Economic Operator (AEO)
Novasep fully compliant with the most stringent international supply chain standards